Skip to main content
BIOVENTIX PLC logo

BIOVENTIX PLC — Investor Relations & Filings

Ticker · BVXP ISIN · GB00B4QVDF07 LEI · 213800225MHX7LZQY108 IL Manufacturing
Open in API
Filings indexed 211 across all filing types
Latest filing 2026-05-18 Major Shareholding Noti…
Country GB United Kingdom
Listing IL BVXP

About BIOVENTIX PLC

https://www.bioventix.com/

Bioventix PLC is a biotechnology company that specializes in the development, creation, and commercial supply of high-affinity sheep monoclonal antibodies (SMAs). These antibodies are utilized by global diagnostic companies as critical components in clinical diagnostic platforms, particularly for blood testing immunoassays. The company's portfolio supports a variety of applications, including diagnostics for cardiovascular conditions (troponin), oncology, and neurodegenerative diseases such as Alzheimer's. In addition to its core antibody products, Bioventix also provides ELISA kits for monitoring exposure to industrial pollutants and offers contract services for the development of new SMAs for healthcare organizations.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 95% confidence The document is a London Stock Exchange RNS TR-1 standard form disclosing a crossing of the 5% threshold in voting rights by Raymond James Wealth Management. This is a notification of a major shareholding change. No financial statements or report attachments are present – it is a straightforward major shareholding notification.
2026-05-18 English
Director Dealing
Director's Dealing Classification · 95% confidence The document is an RNS announcement titled “Director Dealing,” detailing a purchase of the company’s shares by its CFO in accordance with the EU Market Abuse Regulation. It provides insider transaction details (name, position, share quantity, price, date, place). This matches the definition for Director’s Dealing (insider trades by directors).
2026-04-28 English
Share Options Awarded
Director's Dealing Classification · 93% confidence The document is an RNS announcement of share options awarded to executive directors (CEO and CFO), with details of the option grant, exercise price, volume, and regulatory MA requirements. This clearly constitutes insider director dealing (PDMR notification of personal transactions). Thus it matches the “Director’s Dealing” category (DIRS).
2026-04-20 English
Director Dealing
Director's Dealing Classification · 95% confidence The document is a regulatory announcement via RNS detailing an insider transaction by a company director (Non-Executive Chairman Ian Nicholson) purchasing shares. This matches the definition of “Director’s Dealing” (Code: DIRS). It is not an AGM notice, earnings release, or broader report, but specifically an insider share transaction notification.
2026-04-13 English
Director Dealing
Director's Dealing Classification · 95% confidence The document is an RNS announcement detailing insider share purchases by the Chief Executive Officer and his closely associated person, including the number of shares, price, dates, and compliance with the EU Market Abuse Regulation. This is a classic insider transaction/disclosure by directors. It matches the “Director’s Dealing” category.
2026-04-08 English
Director Dealing
Director's Dealing Classification · 95% confidence The document is a notification of a transaction by a person discharging managerial responsibilities (the CFO) purchasing company shares in compliance with EU Market Abuse Regulation. It follows the format for insider transactions (“Director Dealing”) and provides details of name, position, transaction date, volume, price, etc. This fits the “Director’s Dealing” category.
2026-04-02 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.